Voluntary nationwide recall: Eye drops (Rugby)
Nov. 2023Pharmacy Updates
| The Harvard Drug Group LLC has recalled certain lots of Rugby brand eye drops because of bacteria found in certain samples of product. The bacteria could cause eye infections that result in partial vision loss or blindness. As of the date of The Harvard Drug Group LLC’s recall announcement, Oct. 31, 2023, there had been three adverse events reported that were related to these listed products. <a href="https://upmc.widen.net/view/pdf/zgdbu1jhxf/23PV4144001---Eye-Drops-Rugby-Nov-drug-recall_WEB.pdf?t.download=true&u=oid6pr" rel="external">Read the full text of the Rugby brand eye drops recall.</a> |
Recent Announcements
Clinical workflow changes through Epic®
Changes are coming for network providers that utilize Provider OnLine to submit specific information to UPMC Health Plan. Select activities that were previously completed in Provider OnLine will now transition to UPMC Health Plan Tapestry Link.Sep. 2026Important Notices
CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care
Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.Sep. 2026Education/Webinars
Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)
Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).Sep. 2026Pharmacy Updates